Drug interactions
Ipratropium-salbutamol + Solifenacin
Severity: Minor
Ipratropium-salbutamol and Solifenacin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Solifenacin has dose-related QT prolongation and antimuscarinic effects, and salbutamol may add to QT risk. Inhaled ipratropium has minimal systemic absorption, so additive anticholinergic effects are unlikely at normal doses.
What this interaction means in plain words
Ipratropium-salbutamol and Solifenacin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Ipratropium-salbutamol belongs to Respiratory; Solifenacin belongs to Genitourinary.
Why it happens
Possible additive QT prolongation and minor additive antimuscarinic effects.
What to do
No routine action; monitor for anticholinergic symptoms and consider ECG in patients with other QT risk factors.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Other interactions of Solifenacin
Frequently asked questions
Can I take Ipratropium-salbutamol with Solifenacin?
MediHelp rates the interaction as minor. Ipratropium-salbutamol and Solifenacin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Solifenacin has dose-related QT prolongation and antimuscarinic effects, and salbutamol may add to QT risk. Inhaled ipratropium has minimal systemic absorption, so additive anticholinergic effects are unlikely at normal doses.
How serious is the interaction between Ipratropium-salbutamol and Solifenacin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action; monitor for anticholinergic symptoms and consider ECG in patients with other QT risk factors.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
